DSP Clinical Trials

DSP Clinical Trials is a fast-growing, privately-held CRO that has carved out a strong niche in women's health and infertility clinical trials, claiming to have conducted 80% of all U.S. infertility studies over the past 18 years. The company differentiates itself by targeting the underserved small to midsize biopharma segment with a transparent, fixed-price service model designed to avoid overcharging. With experience managing over 200 Phase I-IV trials and 26 New Drug Application (NDA) filings, DSP combines deep therapeutic expertise with a client-centric operational approach. Its recognition on the Inc. 5000 list and as a top women-owned business underscores its rapid growth and unique market position.

Integrated clinical trial service delivery model featuring fixed pricing, dedicated expert teams, and flexible 'On Demand Monitoring' resources. Emphasizes operational efficiency and a simplified contracting process rather than a proprietary technology product.

DSP competes in the fragmented CRO market, differentiating itself by specializing in women's health/infertility and targeting small to midsize sponsors with a transparent pricing model. It faces competition from large, full-service CROs (e.g., IQVIA, ICON) and other specialized, often privately-held, niche CROs.